Scientists have discovered a novel intracellular pathway called antibody-directed xenophagy (ADX) that allows cells to digest pathogens like bacteria and viruses once they enter. This mechanism, regulated by the protein TRIM21, offers a new understanding of the immune system's internal defense. Developers and researchers in biotechnology could explore therapeutic avenues using antibodies or small molecules to leverage ADX for treating infections.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





